Good morning :)
$
₹
McKesson Corporation

McKesson Corporation

MCK

NYSE
Asset Logo

McKesson Corporation

MCK

NYSE
$874.750.54% (-4.81)
$
₹
$874.750.54% (-4.81)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Distribution

Large Cap

With a market cap of $103.4B the stock is ranked 163

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

24.15
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

5.04
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$36.73
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.69
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

1.11%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

0.36%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 17 analysts' reports

Buy
13 analysts
Hold
3 analysts
Sell
1 analyst

Analysts expect a +12.13% price upside over the next year

Current Price$874.75
Target Price$980.73

Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Peers

Peers

Cencora Inc.
COR
Cencora Inc.
P/E Ratio
23.98
23.98
1Y Return
6.55%
6.55%
Buy Reco %
85.71
85.71
Cardinal Health Inc
CAH
Cardinal Health Inc
P/E Ratio
32.16
32.16
1Y Return
51.34%
51.34%
Buy Reco %
64.70
64.70
Henry Schein Inc
HSIC
Henry Schein Inc
P/E Ratio
25.52
25.52
1Y Return
24.05%
24.05%
Buy Reco %
43.75
43.75
Adapthealth Corp
AHCO
Adapthealth Corp
P/E Ratio
—
—
1Y Return
37.52%
37.52%
Buy Reco %
75.00
75.00
EDAP TMS S.A.
FOCL
EDAP TMS S.A.
P/E Ratio
—
—
1Y Return
18.7%
18.7%
Buy Reco %
33.33
33.33

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Distribution

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
McKesson Corporation 24.155.041.69
Cencora Inc.23.9820.220.67
Cardinal Health Inc32.1616.061.16

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

103.1
1.1
106.1
1.1
96.2
1.6
105.3
0.6
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue76.3579.2893.6595.2990.8297.82103.15106.1596.29105.38
Net Income0.790.910.240.871.260.781.111.181.680.61
Net Profit Margin1.03%1.15%0.25%0.92%1.38%0.80%1.07%1.11%1.74%0.58%
See CostsAll values in $ Billion

Frequently asked questions

Frequently asked questions

  1. McKesson Corporation (MCK) share price today is $874.75 as of September 19, 2026 at 1:30 AM IST. The stock touched a day high of $880.75 and a day low of $864.59.

  2. McKesson Corporation stock trades on NYSE under the ticker symbol MCK.

  3. McKesson Corporation's market capitalization is $103.44B as of September 19, 2026 at 1:30 AM IST.

  4. McKesson Corporation's price-to-earnings (P/E) ratio is 24.15 as of September 18, 2026.

  5. McKesson Corporation's price-to-book (P/B) ratio is 5.04 as of September 18, 2026.

  6. Yes, McKesson Corporation pays a dividend, with a current dividend yield of 0.36%.

  7. Yes, You can buy McKesson Corporation shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy McKesson Corporation shares in three steps: 1. Search McKesson Corporation on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since McKesson Corporation trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in McKesson Corporation (MCK) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0114 shares at the current price of $874.75.

Loading...